Open Access
Issue
OCL
Volume 19, Number 4, Juillet-Août 2012
Page(s) 228 - 231
Section Dossier : Absorption intestinale des lipides
DOI https://doi.org/10.1051/ocl.2012.0463
Published online 15 July 2012
  • ANSES. Actualisation des apports nutritionnels conseillés pour les acides gras. Maisons-Alfort : ANSES, 2011. [Google Scholar]
  • Arem R, Ghusn H, Ellerhorst J, Comstock JP. Effect of decreased plasma low-density lipoprotein levels on adrenal and testicular function in man. Clin Biochem 1997 ; 30 : 419–424. [CrossRef] [PubMed] [Google Scholar]
  • Avigan MI, Ishak KG, Gregg RE, Hoofnagle JH. Morphologic features of the liver in abetalipoproteinemia. Hepatology 1984 ; 4 : 1223–1226. [CrossRef] [PubMed] [Google Scholar]
  • Bosner MS, Lange LG, Stenson WF, Ostlund RE Jr. Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry. J Lipid Res 1999 ; 40 : 302–308. [PubMed] [Google Scholar]
  • Chandler CE, Wilder DE, Pettini JL, et al. Cp-346086: An mtp inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans. J Lipid Res 2003 ; 44 : 1887–1901. [CrossRef] [PubMed] [Google Scholar]
  • Cohen JC, Boerwinkle E, Mosley TH, Jr, Hobbs HH. Sequence variations in pcsk9, low ldl, and protection against coronary heart disease. N Engl J Med 2006 ; 354 : 1264–1272. [CrossRef] [PubMed] [Google Scholar]
  • Cohen J, Pertsemlidis A, Kotowski IK, Graham R, Garcia CK, Hobbs HH. Low ldl cholesterol in individuals of african descent resulting from frequent nonsense mutations in pcsk9. Nat Genet 2005 ; 37 : 161–165. [CrossRef] [PubMed] [Google Scholar]
  • Crooke RM, Graham MJ, Lemonidis KM, Whipple CP, Koo S, Perera RJ. An apolipoprotein b antisense oligonucleotide lowers ldl cholesterol in hyperlipidemic mice without causing hepatic steatosis. J Lipid Res 2005 ; 46 : 872–884. [CrossRef] [PubMed] [Google Scholar]
  • Elias N, Patterson BW, Schonfeld G. Decreased production rates of vldl triglycerides and apob-100 in subjects heterozygous for familial hypobetalipoproteinemia. Arterioscler Thromb Vasc Biol 1999 ; 19 : 2714–2721. [CrossRef] [PubMed] [Google Scholar]
  • Ford ES, Li C, Zhao G, Mokdad AH. Concentrations of low-density lipoprotein cholesterol and total cholesterol among children and adolescents in the united states. Circulation 2009 ; 119 : 1108–1115. [CrossRef] [PubMed] [Google Scholar]
  • Fouchier SW, Sankatsing RR, Peter J, et al. High frequency of apob gene mutations causing familial hypobetalipoproteinaemia in patients of dutch and spanish descent. J Med Genet 2005 ; 42 : e23. [CrossRef] [PubMed] [Google Scholar]
  • Gauthier S, Sniderman A. Action tremor as a manifestation of chylomicron retention disease. Ann Neurol 1983 ; 14 : 591. [CrossRef] [PubMed] [Google Scholar]
  • Hercberg S, Preziosi P, Briancon S, et al. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: The su.Vi.Max study–design, methods, and participant characteristics. Supplementation en vitamines et mineraux antioxydants. Control Clin Trials 1998 ; 19 : 336–351. [CrossRef] [PubMed] [Google Scholar]
  • Illingworth DR, Kenny TA, Orwoll ES. Adrenal function in heterozygous and homozygous hypobetalipoproteinemia. J Clin Endocrinol Metab 1982 ; 54 : 27–33. [CrossRef] [PubMed] [Google Scholar]
  • Illingworth DR, Orwoll ES, Connor WE. Impaired cortisol secretion in abetalipoproteinemia. J Clin Endocrinol Metab 1980 ; 50 : 977–979. [CrossRef] [PubMed] [Google Scholar]
  • Jones B, Jones EL, Bonney SA, et al. Mutations in a sar1 gtpase of copii vesicles are associated with lipid absorption disorders. Nat Genet 2003 ; 34 : 29–31. [CrossRef] [PubMed] [Google Scholar]
  • Kim E, Campbell S, Schueller O, et al. A small-molecule inhibitor of enterocytic microsomal triglyceride transfer protein, slx-4090: Biochemical, pharmacodynamic, pharmacokinetic, and safety profile. J Pharmacol Exp Ther 2011 ; 337 : 775–785. [CrossRef] [PubMed] [Google Scholar]
  • Lacaille F, Bratos M, Bouma ME, Jos J, Schmitz J, Rey J. Anderson’s disease. Clinical and morphologic study of 7 cases. Arch Fr Pediatr 1989 ; 46 : 491–498. [PubMed] [Google Scholar]
  • Lambert D, Daubrosse E, Steinmetz J, Siest G, Debry G. Reference values of plasma and lipoprotein cholesterol and triacylglycerols in healthy children. Arch Fr Pediatr 1984 ; 41 : 145–150. [PubMed] [Google Scholar]
  • Leppert M, Breslow JL, Wu L, et al. Inference of a molecular defect of apolipoprotein b in hypobetalipoproteinemia by linkage analysis in a large kindred. J Clin Invest 1988 ; 82 : 847–851. [CrossRef] [PubMed] [Google Scholar]
  • Muller DP, Lloyd JK, Bird AC. Long-term management of abetalipoproteinaemia. Possible role for vitamin e. Arch Dis Child 1977 ; 52 : 209–214. [CrossRef] [PubMed] [Google Scholar]
  • NIH. The lipid research clinics population studies data book. BETHESDA, National Heart and Lung Institute, 1980, 1. [Google Scholar]
  • Partin JS, Partin JC, Schubert WK, McAdams AJ. Liver ultrastructure in abetalipoproteinemia: Evolution of micronodular cirrhosis. Gastroenterology 1974 ; 67 : 107–118. [PubMed] [Google Scholar]
  • Peretti N, Roy CC, Sassolas A, et al. Chylomicron retention disease: A long term study of two cohorts. Mol Genet Metab 2009 ; 97 : 136–142. [CrossRef] [PubMed] [Google Scholar]
  • Peretti N, Sassolas A, Roy CC, et al. Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers. Orphanet J Rare Dis 2010 ; 5 : 24. [CrossRef] [PubMed] [Google Scholar]
  • Roy CC, Levy E, Green PH, et al. Malabsorption, hypocholesterolemia, and fat-filled enterocytes with increased intestinal apoprotein b. Chylomicron retention disease. Gastroenterology 1987 ; 92 : 390–399. [PubMed] [Google Scholar]
  • Sankatsing RR, Fouchier SW, de Haan S, et al. Hepatic and cardiovascular consequences of familial hypobetalipoproteinemia. Arterioscler Thromb Vasc Biol 2005 ; 25 : 1979–1984. [CrossRef] [PubMed] [Google Scholar]
  • Schonfeld G, Patterson BW, Yablonskiy DA, et al. Fatty liver in familial hypobetalipoproteinemia: Triglyceride assembly into vldl particles is affected by the extent of hepatic steatosis. J Lipid Res 2003 ; 44 : 470–478. [CrossRef] [PubMed] [Google Scholar]
  • Sehayek E, Nath C, Heinemann T, et al. U-shape relationship between change in dietary cholesterol absorption and plasma lipoprotein responsiveness and evidence for extreme interindividual variation in dietary cholesterol absorption in humans. J Lipid Res 1998 ; 39 : 2415–2422. [PubMed] [Google Scholar]
  • Silvain M, Bligny D, Aparicio T, et al. Anderson’s disease (chylomicron retention disease): A new mutation in the sara2 gene associated with muscular and cardiac abnormalities. Clin Genet 2008 ; 74 : 546–552. [CrossRef] [PubMed] [Google Scholar]
  • Strich D, Goldstein R, Phillips A, et al. Anderson’s disease: No linkage to the apo b locus. J Pediatr Gastroenterol Nutr 1993 ; 16 : 257–264. [CrossRef] [PubMed] [Google Scholar]
  • Tarugi P, Averna M. Hypobetalipoproteinemia: Genetics, biochemistry, and clinical spectrum. Adv Clin Chem 2011 ; 54 : 81–107. [CrossRef] [PubMed] [Google Scholar]
  • Traber MG, Sokol RJ, Ringel SP, Neville HE, Thellman CA, Kayden HJ. Lack of tocopherol in peripheral nerves of vitamin e-deficient patients with peripheral neuropathy. N Engl J Med 1987 ; 317 : 262–265. [CrossRef] [PubMed] [Google Scholar]
  • Wetterau JR, Aggerbeck LP, Bouma ME, et al. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 1992 ; 258 : 999–1001. [CrossRef] [PubMed] [Google Scholar]
  • Wu J, Kim J, Li Q, et al. Known mutations of apob account for only a small minority of hypobetalipoproteinemia. J Lipid Res 1999 ; 40 : 955–959. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.